Last updated on August 2016

Phase 1 Study of MM-398 Plus Cyclophosphamide in Pediatric Solid Tumors


Brief description of study

This is a Phase 1 study of the combination of two drugs: MM-398 and Cyclophosphamide. The goal is to find the highest dose of MM-398 that can be given safely when it is used together with the chemotherapy drug Cyclophosphamide.

Clinical Study Identifier: NCT02013336

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Amanda Knight, RN, BSN, CCRP

Oklahoma City, OK United States
  Connect »

Amanda Knight, RN, BSN, CCRP

Ft Worth, TX United States
  Connect »

Amanda Knight, RN, BSN, CCRP

San Antonio, TX United States
  Connect »

Amanda Knight, RN, BSN, CCRP

Milwaukee, WI United States
  Connect »